Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1MBB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,438
Award facts
- Contract value 100% obligated
- $12,438.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,438.15 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) with a firm fixed-price contract type. The award was made on January 14, 2026, with an ultimate completion date of February 5, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements through open competition. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company supplies a comprehensive portfolio of medications and medical commodities across multiple therapeutic domains, with this particular delivery order supporting the Defense Health Agency and other government healthcare providers. The IDC vehicle under which this award falls represents a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to fulfill essential medical supply needs for military treatment facilities and federal healthcare institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F1MBB?
SPE2DR26F1MBB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F1MBB worth?
The government has obligated $12,438 on SPE2DR26F1MBB.
Is contract SPE2DR26F1MBB an order under another contract?
Yes. SPE2DR26F1MBB is a delivery order under SPE2DR25D2215, an indefinite delivery contract.
Was contract SPE2DR26F1MBB competed?
The extent of competition for SPE2DR26F1MBB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award